about
Association between a functional interleukin-6 gene polymorphism and peak bone mineral density and postmenopausal bone loss in women: the OFELY studyIdentification of osteopenic women at high risk of fracture: the OFELY study.Alterations of cortical and trabecular architecture are associated with fractures in postmenopausal women, partially independent of decreased BMD measured by DXA: the OFELY study.Diagnostic accuracy of FRAX in predicting the 10-year risk of osteoporotic fractures using the USA treatment thresholds: A systematic review and meta-analysis.Microarchitecture and Peripheral BMD are Impaired in Postmenopausal White Women With Fracture Independently of Total Hip T-Score: An International Multicenter StudyBone Microarchitecture Assessed by HR-pQCT as Predictor of Fracture Risk in Postmenopausal Women: The OFELY Study.Serum periostin is associated with prevalent knee osteoarthritis and disease incidence/progression in women: the OFELY study.Finite element analysis performed on radius and tibia HR-pQCT images and fragility fractures at all sites in postmenopausal women.Trabecular bone score improves fracture risk prediction in non-osteoporotic women: the OFELY study.Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study.Urinary levels of pentosidine and the risk of fracture in postmenopausal women: the OFELY study.In obese postmenopausal women, bone microarchitecture and strength are not commensurate to greater body weight: the Os des Femmes de Lyon (OFELY) study.Teenagers and young adults with nephropathic cystinosis display significant bone disease and cortical impairment.Serum Sclerostin Increases After Acute Physical Activity.Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study.Homocysteine and fracture risk in postmenopausal women: the OFELY study.Serum periostin is associated with fracture risk in postmenopausal women: a 7-year prospective analysis of the OFELY study.Family resemblance of bone turnover rate in mothers and daughters--the MODAM study.Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use: the OFELY study.Age-related changes in bone strength from HR-pQCT derived microarchitectural parameters with an emphasis on the role of cortical porosity.Local topological analysis at the distal radius by HR-pQCT: Application to in vivo bone microarchitecture and fracture assessment in the OFELY study.The impact of osteoporosis on quality-of-life: the OFELY cohort.Bone remodelling in humans is load-driven but not lazy.Influence of blinding sequence of radiographs on the reproducibility and sensitivity to change of joint space width measurement in knee osteoarthritisCortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective studySelected serum microRNA, abdominal aortic calcification and risk of osteoporotic fracture.Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective studyBiochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY studyLongitudinal study of bone loss in pre- and perimenopausal women: evidence for bone loss in perimenopausal womenBone fragility: failure of periosteal apposition to compensate for increased endocortical resorption in postmenopausal womenContribution of trochanteric soft tissues to fall force estimates, the factor of risk, and prediction of hip fracture riskAssociation between spine disc degeneration and type II collagen degradation in postmenopausal women: the OFELY studyFinite element analysis based on in vivo HR-pQCT images of the distal radius is associated with wrist fracture in postmenopausal womenAge determines longitudinal changes in body composition better than menopausal and bone status: the OFELY studyThe FRAX tool in French women: How well does it describe the real incidence of fracture in the OFELY cohort?Early impairment of trabecular microarchitecture assessed with HR-pQCT in patients with stage II-IV chronic kidney diseaseImpaired trabecular and cortical microarchitecture in daughters of women with osteoporotic fracture: the MODAM studyHow to predict fragility fracture beyond 10 years? The OFELY studyMuscle mass is associated with incident fracture in postmenopausal women: The OFELY studyDeterioration of Cortical and Trabecular Microstructure Identifies Women With Osteopenia or Normal Bone Mineral Density at Imminent and Long-Term Risk for Fragility Fracture: A Prospective Study
P50
Q28214042-7FE10414-E739-4633-A85E-EA1D2C6FF62FQ34450708-7C8F160B-11EE-44ED-8571-F8D26FAD6375Q34593182-877619E8-49FD-4CDE-B5AB-630C2E23E37AQ36301376-9FFCAA78-3EA1-43C6-B30C-0E68A8DA5C38Q36963613-F1925590-D09A-482A-84F2-0932F0473650Q40300847-E276969B-8B98-4E9F-BA32-64E21FA448F6Q41671600-9EB39E9C-E974-46C6-B9CD-D1DAEBC4D01AQ43998062-4CDD6905-0CCC-4C5D-A38F-C7837DA887A5Q44194587-5E4CB446-BCC9-4281-AD14-19C32159B09EQ45268599-8A67E3CA-DAEA-4896-8A67-E848CB66225DQ46022308-F5708634-EEA1-4972-911D-028693B537E0Q46356182-E1937505-9352-4F3C-861E-CED58B9B176FQ50051475-13FDC6D2-3F01-4765-8752-E24BF0AA36EBQ50751681-E56663CF-29A2-40F7-8C5E-58D9E0546AEDQ50792778-26F8191C-A370-4FB5-83D0-0D6B405BF9D2Q51102387-49AC619B-AFD2-40BE-9906-780BD849B665Q51241729-26C3A40F-EBCF-44CE-A806-03B206A7A283Q51310732-D4143579-3610-4F1A-981E-C7344141A8D9Q51533603-7BE3295F-B8FA-4B16-94B3-1C613EF1806DQ51662318-7DEE1B50-CCD7-4B61-AB23-22297E876C99Q53155228-39C8EEF7-D042-4979-9123-C9E3B1D54EE0Q53427062-8E76BC99-5A35-46B0-9381-057DD1F9609BQ53450107-230CC187-141F-48A9-BDB9-4659BD501D3FQ57779782-485613C5-50C2-4495-A47D-468F629CD626Q61480153-D3956940-1B5E-4D6A-9BAF-8ABC8AFABA70Q64969313-3545D5DE-C181-43C6-9B7E-1273FF05BEF7Q74091282-F082278D-5320-426C-AEDC-AA499371B507Q74141058-9EC9ECCA-3B0C-450D-9E68-0FD51469B77DQ74301914-8D010A23-58D4-4FA7-840B-0347CFD11F41Q79141911-2D770DEF-C500-456C-ABF4-FAB59DF56304Q79921446-6D328F5F-64FE-4372-BB01-89A445331CC5Q80845216-A5BB97BE-0D28-4DEB-93DA-212F5E81314CQ81588606-56864BB8-B6A4-4DFC-BA62-93F3C1F81A7DQ82564441-76E01661-344B-4F89-BF73-03AA98CA6724Q84293855-935F9FF8-B7F2-4E42-ABB6-D7223622F576Q84581714-2AE2DA36-3A1C-4F9D-9EE8-650633CACE79Q85524108-5A91022A-300C-4105-B7EB-6C5BDA0DEA38Q85631987-9420F4AD-E8A6-4816-9019-6167430D1387Q89007269-75C89E34-31D1-486F-BCEE-CA11C37EE352Q91845365-6655F653-CEC6-4B8C-BAA1-0E11F15A7517
P50
description
researcher
@en
wetenschapper
@nl
name
E Sornay-Rendu
@en
E Sornay-Rendu
@nl
type
label
E Sornay-Rendu
@en
E Sornay-Rendu
@nl
prefLabel
E Sornay-Rendu
@en
E Sornay-Rendu
@nl
P106
P31
P496
0000-0002-2573-5316